This article is a correction to:
Circulating Polyunsaturated Fatty Acids and COVID-19: A Prospective Cohort Study and Mendelian Randomization Analysis
Yitang Sun
Radhika Chatterjee1
Kaixiong Ye- 1Department of Genetics, Franklin College of Arts and Sciences, University of Georgia, Athens, GA, United States
- 2Institute of Bioinformatics, University of Georgia, Athens, GA, United States
A corrigendum on
Circulating polyunsaturated fatty acids and COVID-19: a prospective cohort study and Mendelian randomization analysis
by Sun, Y., Chatterjee, R., Ronanki, A., and Ye, K. (2022). Front. Med. 9:923746. doi: 10.3389/fmed.2022.923746
In the published article, there was an error. Acknowledgments of the Framingham Heart Study were not included. A correction has been made to Acknowledgments. This sentence previously stated:
“This study was approved by the University of Georgia Institutional Review Board and the UK Biobank consortium (application no. 48818). We thank the investigators of the COVID-19 Host Genetics Initiative for sharing the GWAS summary statistics.”
The corrected sentence appears below:
“This study was approved by the University of Georgia Institutional Review Board and the UK Biobank consortium (application no. 48818). We thank the investigators of the COVID-19 Host Genetics Initiative for sharing the GWAS summary statistics. The Framingham Heart Study is conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with Boston University (Contract Nos. N01-HC-25195, HHSN268201500001I and 75N92019D00031). This manuscript was not prepared in collaboration with investigators of the Framingham Heart Study and does not necessarily reflect the opinions or views of the Framingham Heart Study, Boston University, or NHLBI. Funding for SHARe Affymetrix genotyping was provided by NHLBI Contract N02-HL-64278. SHARe Illumina genotyping was provided under an agreement between Illumina and Boston University. Funding for Affymetrix genotyping of the FHS Omni cohorts was provided by Intramural NHLBI funds from Andrew D. Johnson and Christopher J. O'Donnell. Funding support for the Framingham Red Blood Cell Fatty Acids dataset was provided by NHLBI grant R01 HL089590.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: COVID-19, polyunsaturated fatty acid, Mendelian randomization, prospective cohort, docosapentaenoic acid, arachidonic acid
Citation: Sun Y, Chatterjee R, Ronanki A and Ye K (2023) Corrigendum: Circulating polyunsaturated fatty acids and COVID-19: a prospective cohort study and Mendelian randomization analysis. Front. Med. 10:1190514. doi: 10.3389/fmed.2023.1190514
Received: 21 March 2023; Accepted: 31 March 2023;
Published: 12 April 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Sun, Chatterjee, Ronanki and Ye. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Kaixiong Ye, a2FpeGlvbmcueWUmI3gwMDA0MDt1Z2EuZWR1